Sara Yankelev

615 total citations
8 papers, 502 citations indexed

About

Sara Yankelev is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Sara Yankelev has authored 8 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Sara Yankelev's work include Antimicrobial Resistance in Staphylococcus (4 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Sara Yankelev is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Sara Yankelev collaborates with scholars based in United States, United Kingdom and Russia. Sara Yankelev's co-authors include David P. Benziger, Mark Benvenuto, Gloria Vigliani, Kenneth C. Lamp, Lawrence V. Friedrich, John Mohr, Joseph S. Solomkin, Ian R. Friedland, Christopher Lucasti and Benjamin Miller and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents and Southern Medical Journal.

In The Last Decade

Sara Yankelev

8 papers receiving 484 citations

Peers

Sara Yankelev
Maria Amodio-Groton United States
A. M. Lovering United Kingdom
Jill Butterfield United States
David P. Nicolau United States
Jean Li Yan United States
Dora E. Wiskirchen United States
D L Rotella United States
Amira A. Bhalodi United States
Maria Amodio-Groton United States
Sara Yankelev
Citations per year, relative to Sara Yankelev Sara Yankelev (= 1×) peers Maria Amodio-Groton

Countries citing papers authored by Sara Yankelev

Since Specialization
Citations

This map shows the geographic impact of Sara Yankelev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Yankelev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Yankelev more than expected).

Fields of papers citing papers by Sara Yankelev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Yankelev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Yankelev. The network helps show where Sara Yankelev may publish in the future.

Co-authorship network of co-authors of Sara Yankelev

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Yankelev. A scholar is included among the top collaborators of Sara Yankelev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Yankelev. Sara Yankelev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lucasti, Christopher, Ellie Hershberger, Benjamin Miller, et al.. (2014). Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections. Antimicrobial Agents and Chemotherapy. 58(9). 5350–5357. 93 indexed citations
3.
Knapp, Andrew, et al.. (2011). Prospective, Non-Comparative Study of Daptomycin for the Treatment of Superficial and Deep Incisional Surgical Site Infections. Surgical Infections. 12(2). 113–118. 5 indexed citations
4.
Benziger, David P., Peter Pertel, Sara Yankelev, et al.. (2011). Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.. PubMed. 75(1). 63–9. 13 indexed citations
5.
Friedman, Bruce, et al.. (2010). A Retrospective Review of Clinical Experience with Daptomycin for a Variety of Wound Types in a Burn and Wound Care Facility. Southern Medical Journal. 103(8). 748–752. 2 indexed citations
6.
Mohr, John, Lawrence V. Friedrich, Sara Yankelev, & Kenneth C. Lamp. (2009). Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE). International Journal of Antimicrobial Agents. 33(6). 543–548. 56 indexed citations
7.
Benvenuto, Mark, David P. Benziger, Sara Yankelev, & Gloria Vigliani. (2006). Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 50(10). 3245–3249. 257 indexed citations
8.
Blumenthal, M, Sara Yankelev, & S. Dikstein. (1976). Method for Antiglaucoma Drug Screening on Rabbits. Ophthalmic Research. 8(4). 259–261. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026